Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black americans

New England Journal of Medicine

Volumn 336, Issue 7, 1997, Pages 466-473

  Jacobson, Daniel R ^a,b   Pastore, Raymond D ^a   Yaghoubian, Robert ^a   Kane, Immaculata ^a   Gallo, Gloria ^b   Buck, Francis S ^c   Buxbaum, Joel N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; HEART AMYLOIDOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; CARDIOMYOPATHIES; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREALBUMIN; UNITED STATES;

EID: 0031028712     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199702133360703     Document Type: Article

References (48)

1. Soyka J. Ueber amyloide Degeneration. Prag Med Wochenschr 1876;1: 165-71.
2. Beneke R, Bönning F. Ein Fall von lokaler Amyloidose des Herzens. Beitr Pathol Anat 1908;44:362-85.
3. Buerger L, Braunstein H. Senile cardiac amyloidosis. Am J Med 1960; 28:357-67.
4. Wright JR, Calkins E. Amyloid in the aged heart: frequency and clinical significance. J Am Geriatr Soc 1975;23:97-103.
5. Wright JR, Calkins E, Breen WJ, Stolte G, Schultz RT. Relationship of amyloid to aging: review of the literature and systematic study of 83 patients derived from a general hospital population. Medicine (Baltimore) 1969;48:39-60.
6. Pomerance A. Age-related cardiovascular changes and mechanically induced endocardial pathology. In: Silver MD, ed. Cardiovascular pathology. 2nd ed. New York: Churchill Livingstone, 1991:155-62.
7. Hodkinson HM, Pomerance A. The clinical significance of senile cardiac amyloidosis: a prospective clinico-pathological study. Q J Med 1977;46: 381-7.
8. Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988;63:552-64.
9. Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968;47:2025-44.
10. Bartalena L, Robbins J. Variations in thyroid hormone transport proteins and their clinical implications. Thyroid 1992;2:237-45.
11. Gustavsson Å, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995;73:703-8.
12. Christmanson L, Betsholtz C, Gustavsson A, Johansson B, Sletten K, Westermark P. The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis. FEBS Lett 1991;281:177-80.
13. Jacobson DR, Gertz MA, Kane I, Buxbaum JN. Genetic analysis of 9 unrelated patients with transthyretin (TTR)-cardiac amyloidosis: correlation of clinical and genetic findings and description of 2 new TTR variants. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and amyloidosis 1993. New York: Parthenon Publishing, 1994:474-6.
14. Jacobson DR, Buxbaum JN. Genetic aspects of amyloidosis. Adv Hum Genet 1991;20:69-123, 309-11.
15. Benson MD, Uemichi T. Transthyretin amyloidosis. Amyloid Int J Exp Clin Invest 1996;3:44-56.
16. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis: identification of a new prealhumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-43.
17. Jacobson DR, Gorevic PD, Buxbaum JN. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet 1990;47:127-36.
18. Nichols WC, Liepnieks JJ, Snyder EL, Benson MD. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). J Lab Clin Med 1991;117:175-80.
19. Saraiva MJM, Sherman W, Marboe C, et al. Cardiac amyloidosis: report of a patient heterozygous for the transthyretin-isoleucine 122 variant. Scand J Immunol 1990;32:341-6.
20. Jacobson DR, Ittmann M, Buxbaum JN, Wieczorek R, Gorevic PD. Cardiac amyloidosis resulting from transthyretin Ile 122 deposition in African-Americans: two case reports. Texas Heart Inst J (in press).
21. Blacks. In: Russell C. The official guide to racial and ethnic diversity. Ithaca, N.Y.: New Strategist, 1996:71-188.
22. Jacobson DR, Pastore R, Pool S, et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996;98:236-8.
23. Jacobson DR, Reveille JD, Buxbaum JN. Frequency and genetic back ground of the position 122 (Val→Ile) variant transthyretin gene in the black population. Am J Hum Genet 1991;49:192-8.
24. Almeida MR, Altland K, Rauh S, et al. Characterization of a basic transthyretin variant - TTR Arg 102 - in the German population. Biochim Biophys Acta 1991;1097:224-6.
25. Alves IL, Altland K, Almeida MR, Becher P, Costa PP, Saraiva MJM. Screening of TTR variants in the Portuguese population by HIEF. J Rheu matol 1993;20:185. abstract.
26. Buck FS, Koss MN, Sherrod AE, Wu A, Takahashi M. Ethnic distribution of amyloidosis: an autopsy study. Mod Pathol 1989;2:372-7.
27. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-55.
28. Gallo GR, Feiner HD, Chuba JV, Bencck D, Marion P, Cohen DH. Characterization of tissue amyloid by immunofluorescence microscopy. Clin Immunol Immunopathol 1986-39:479-90.
29. Mills NE, Fishman CL, Scholes J, Anderson SE, Rom WN, Jacobson DR. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J Natl Cancer Inst 1995;87:1056-60. [Erratum, J Natl Cancer Inst 1995;87:1643.]
30. Jacobson DR, Buxbaum JN. A double-variant transthyretin allele (Ser 6, Ile 33) in the Israeli patient "SKO" with familial amyloidotic polyneuropathy. Hum Mutat 1994;3:254-60.
31. Jacobson DR. A specific test for transthyretin 122 (Val→Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks. Am J Hum Genet 1992;50:195-8.
32. Kwok S. Procedures to minimize PCR-product carry-over. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:142-5.
33. Greer CE, Lund JK, Manos MM. PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies. PCR Methods Appl 1991;1:46-50.
34. Navidi W, Arnheim N, Waterman MS. A multiple-tubes approach for accurate genotyping of very small DNA samples by using PCR: statistical considerations. Am J Hum Genet 1992;50:347-59.
35. Gallo G, Picken M, Frangione B, Buxbaum J. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component. Mod Pathol 1988;1:453-6.
36. Jones RS, Frazier DB. Primary cardiovascular amyloidosis: its clinical manifestations, pathology and histogenesis. Arch Pathol 1950;50:366-84.
37. Coelho T, Sousa A, Lourenco E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994;31:293-9.
38. Grateau G, Adams D, Malapert D, Viemont M, Delpech M, Said G. Late-onset familial amyloid polyneuropathy with the TTR Met 30 mutation in France. Clin Genet 1993;43:143-5.
39. Skinner M, Anderson JJ, Simms R, et al. Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only. Am J Med 1996;100:290-8.
40. Kyle RA, Gertz MA, Garton JP, Greipp PR, Witzig TE, Lust JA. Primary systemic amyloidosis (AL): randomized trial of colchicine vs. melphalan and prednisone vs. melphalan, prednisone, and colchicine. In: Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ, Young ID, eds. Amyloid and amyloidosis 1993. New York: Parthenon Publishing, 1994:648-50.
41. Suhr OB, Holmgren G, Steen L, et al. Liver transplantation in familial amyloidotic polyneuropathy: follow-up of the first 20 Swedish patients. Transplantation 1995;60:933-8.
42. Skinner M, Lewis WD, Jones LA, et al. Liver transplantation as a treatment for familial amyloidotic polyneuropathy. Ann Intern Med 1994;120: 133-4.
43. Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation 1981;63:1285-8.
44. Griffiths BE, Hughes P, Dowdle R, Stephens MR. Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine. Thorax 1982;37:711-2.
45. Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol 1985;55:1645.
46. WHO-IUIS Nomenclature Sub-Committee. Nomenclature of amyloid and amyloidosis. Bull World Health Organ 1993;71:105-8.
47. Husby G. Nomenclature and classification of amyloid and amyloidoses J Intern Med 1992;232:511-2.
48. Public Health Service. Healthy People 2000: national health promotion and disease prevention objectives. Washington, D.C.: Government Printing Office, 1991:46. (DHHS publication no. (PHS) 91-50212.)